Menu
ncarol.com
  • Home
  • Music
  • Books
  • Manufacturing
  • Asheville Music
  • Health
  • Book Release
  • Business
  • Technology
ncarol.com

Covid Conditions Intensify Opioid Overdose Deaths
ncarol.com/10099682

Trending...
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
Kansas City Turnkey 120 Bed Inpatient Facility Kansas City Turnkey 120 Bed Inpatient Facility Kansas City Turnkey Inpatient Facility KC Turnkey Inpatient Facility Nurse's Statation KC Turnkey Residential Care Facility Double Room
Pandemic Exacerbates Scarcity of Substance Abuse Inpatient Treatment Facilities Nationwide

KANSAS CITY, Mo. - ncarol.com -- COVID-19 is fueling an explosion in drug overdose deaths nationally. Drug overdose deaths soared nationally to the highest number ever recorded.

It's been "like pouring gasoline on a fire," says Lane Slaten founder and CEO of CWMN LLC, national developer of behavioral health inpatient facilities.

The CDC says the latest numbers suggest an acceleration of overdose deaths during the pandemic. Nationwide, they rose 26% in the 12 months ending in May. Covid circumstances have more people seeking addiction and mental health help, but treatment centers are in short supply, which is exacerbating opioid overdose deaths. "The problem is there is an enormous shortage of substance abuse inpatient treatment facilities nationwide," said Slaten.

In this covid climate, there has been a flood of private equity (PE) investment paying close attention, and private-equity firms are starting to pile into the new business opportunity of addiction treatment facilities, drawn by soaring demand, expanded insurance coverage, and the chance to consolidate a highly fragmented market. The firms are acquiring or expanding clinics that provide everything from detox and residential care to outpatient and methadone treatment. In some cases, private-equity firms have approached not-for-profit outfits in an attempt to buy and convert them to for-profit entities, say treatment-center executives.

More on ncarol.com
  • Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
  • FOCUS Names Mark Phillips Senior Vice President of Business Development
  • Notaron Expands Online Notarization Access Following Wisconsin Approval
  • Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October

Mr. Slaten is positioning himself to become the "driving force" in growing turnkey-ready inpatient facilities from coast-to-coast. "I'm committed to developing up to three large residential care facilities a year to help dampen the coming inferno post covid," Slaten explained. Currently he is finalizing the development of his second inpatient facility in the Kansas City Metropolitan Area. It's a 86,000 SF turnkey-ready 120 bed capacity residential care facility that was recently listed on LoopNet.com for $7,900,000. More property information can be found at www.InpatientFacility.com or take a quick video tour.



For More Info Contact:

Lane Slaten
CWMN, LLC
Founder & CEO
913-444-9911
Lane's LinkedIn: @lane-slaten

Source: CWMN, LLC
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
  • Google AI Says KayeDinero Isn't the Greatest Female Producer. She Asks: Who Decides?
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
  • From Michael Jackson to Drake: The Artists Who Shaped KayeDinero's Sound
  • L-Tron to Attend the 2026 NC, GA, TN, SC Joint Regional IAI Conference
  • "Kulture Metrics" Isn't Just an Album Title: KayeDinero Connects Music, Markets and Code
  • Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
  • Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • Pipeline Developer Isn't Just a Song: KayeDinero Builds Software, Markets and Music
  • Who Is KayeDinero? The Asheville Artist Also Builds Software and Trading Systems
  • Leaping Cat Creative Takes Shape Around the Problems Nobody Quite Owns
  • White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
  • Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
  • As Boone Takes Art to the Streets, KayeDinero Asks What Makes Creativity Human
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Black Mountain Meets "Human Error": KayeDinero on What Technology Can't Reproduce
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 156
  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 155
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 139
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate - 133
  • BumbleBeeSmart Launches Dedicated Sensory Wall Panels Collection for Adults, Memory Care and Senior Living - 123
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 123
  • Bspin Launches Lightning-Fast Crypto Gaming Expansion With Sportsbook, Poker, VIP Rewards, and Bitcoin Lightning Network Integration - 122
  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners - 121
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History - 120
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies - 113

Similar on ncarol.com

  • International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
  • Notaron Expands Online Notarization Access Following Wisconsin Approval
  • The Social Capital Revolution Comes to Phoenix!
  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
  • Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute